Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Acadia Healthcare (ACHC) PT Raised to $95 at Jefferies
July 28, 2022 8:00 AM EDTJefferies analyst Brian Tanquilut raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $95.00 (from $85.00) while maintaining a Buy rating.
The analyst commented, "ACHC's strong Q2 results and accompanying guidance raise highlight mgmt's continued ability to deliver growth and execute,... More
Acadia Healthcare (ACHC) Tops Q2 EPS by 10c; Offers FY22 Guidance
July 27, 2022 4:14 PM EDTAcadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.88, $0.10 better than the analyst estimate of $0.78. Revenue for the quarter came in at $651.7 million versus the consensus estimate of $650.82 million.
GUIDANCE:
Acadia Healthcare sees FY2022 EPS of $2.93-$3.18, versus the consensus of... More
